ApprovalTrail

Ingredient

Erythromycin

Products in Health Canada’s databases that list Erythromycin as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.

Also listed as “Erythromycin (Erythromycin Stearate)” (7); “Erythromycin (Erythromycin Phosphate)” (4). How names are joined

Drug products
53
8 authorized now
Natural health products
0
0 active licences
Notices of Compliance
23
Products in all
53

Drug products

Authorized products first.

NameDINStatus
BENZAMYCIN (3 %)Bausch Health, Canada Inc. · Status since Oct 202002225271Marketed
ERYTHROMYCIN (5 MG)Pharma Stulln Inc. · Status since Jul 202302141574Marketed
ERYTHROMYCIN OPHTHALMIC OINTMENT USP (5 MG)Steri-Med Pharma Inc. · Status since Apr 202202326663Marketed
PDP-ERYTHROMYCIN (5 MG)Pendopharm Division Of Pharmascience Inc · Status since Jun 201501912755Marketed
ERYTHRO-BASE (250 MG)AA Pharma Inc. · Status since Feb 202200682020Dormant
ERYTHRO-S (250 MG)AA Pharma Inc. · Status since Jul 202000545678Dormant
ODAN-ERYTHROMYCIN (5 MG)Odan Laboratoriesltd · Status since Jun 202000641324Dormant
PMS-ERYTHROMYCIN (5 MG)Pharmascience Inc. · Status since Sep 201902492350Approved
ALTI-ERYTHROMYCIN TAB 250MG USP (250 MG)Altimed Pharma Inc. · Status since Sep 199900640263Cancelled Post Market
EMYCIN ECT 250MG (250 MG)The Upjohn Company Of Canada · Status since Sep 199600030899Cancelled Post Market
ERYBID (500 MG)Amdipharm Limited · Status since Jun 201700893862Cancelled Post Market
ERYC DELAYED-RELEASE CAPSULES (250 MG)Pfizer Canada Ulc · Status since Apr 202000607142Cancelled Post Market
ERYC DELAYED-RELEASE CAPSULES (333 MG)Pfizer Canada Ulc · Status since Apr 202300873454Cancelled Post Market
ERYMYCIN OPHTHALMIC OINTMENT 5MG/G (5 MG)Mm Therapeutics Inc · Status since Jan 201102237041Cancelled Post Market
ERYSOL (2 %)Glaxosmithkline Inc · Status since Feb 201502034506Cancelled Post Market
ERYTHRO 200 (200 MG)P.V.U., Division Of Vétoquinol N.-A. Inc. · Status since Sep 199700532290Cancelled Post Market
ERYTHRO 36 (50 MG)P.V.U., Division Of Vétoquinol N.-A. Inc. · Status since Sep 199700532266Cancelled Post Market
ERYTHRO-200 (STERILE INJECTION) (200 MG)Vetoquinol N A Inc · Status since Jul 201402172690Cancelled Post Market
ERYTHRO-36 - LIQ IMM 50MG/ML (50 MG)Vetoquinol N A Inc · Status since Aug 201602172607Cancelled Post Market
ERYTHRO-BASE TAB 250MG USP (250 MG)Pro Doc Limitee · Status since Jul 200900704385Cancelled Post Market
ERYTHRO-DRY COW - LIQ IMM 50MG/ML (50 MG)P.V.U., Division Of Vétoquinol N.-A. Inc. · Status since Jul 200402172615Cancelled Post Market
ERYTHRO-DRY COW 600MG/12ML (600 MG)P.V.U., Division Of Vétoquinol N.-A. Inc. · Status since Aug 200100532266Cancelled Post Market
ERYTHRO-EC (250 MG)AA Pharma Inc. · Status since Nov 201400726672Cancelled Post Market
ERYTHRO-EC (333 MG)AA Pharma Inc. · Status since Nov 201401925938Cancelled Post Market
ERYTHRO-MED (115.6 MG)Bio Agri Mix Lp · Status since Jun 202202030578Cancelled Post Market
ERYTHRO-S (500 MG)AA Pharma Inc. · Status since Jan 201900688568Cancelled Post Market
ERYTHROCIN FILMTAB 250MG (250 MG)Abbott Laboratories Co. · Status since Aug 199900000434Cancelled Post Market
ERYTHROCIN FILMTAB 500MG (500 MG)Abbott Laboratories Co. · Status since Aug 199900266515Cancelled Post Market
ERYTHROMID TAB 250MG (250 MG)Abbott Laboratories Co. · Status since Jun 200800244635Cancelled Post Market
ERYTHROMYCIN (462.4 MG)Canada Life Sciences · Status since Dec 202102282712Cancelled (Unreturned Annual)
ERYTHROMYCIN CAPSULES USP 250MG (250 MG)Laboratoires Confab Inc. · Status since Apr 202102235885Cancelled Pre Market
ERYTHROMYCIN OPHTHALMIC OINTMENT U.S.P. (5 MG)Rivex Ophthalmics Inc. · Status since Jul 200302212935Cancelled Post Market
ERYTHROMYCIN STEARATE TABLETS USP 250MG (250 MG)Laboratoires Confab Inc. · Status since Apr 202102235887Cancelled Pre Market
EURO-ERYTHROMYCIN OPHTHALMIC OINTMENT USP (5 MG)Euro-Pharm International Canada Inc. · Status since Jun 202502460211Cancelled Pre Market
GALLIMYCIN (115.6 MG)Vetoquinol N A Inc · Status since Apr 201600531960Cancelled Post Market
GALLIMYCIN 100 INJ 100MG/ML (100 MG)P.V.U., Division Of Vétoquinol N.-A. Inc. · Status since Aug 200100595055Cancelled Post Market
GALLIMYCIN 200 INJ (200 MG)A.P.A., Division Of Vétoquinol N.-A. Inc. · Status since Sep 199700531987Cancelled Post Market
GALLIMYCIN 36 INJ 50MG/ML (50 MG)A.P.A., Division Of Vétoquinol N.-A. Inc. · Status since Nov 200000532037Cancelled Post Market
GALLIMYCIN PFC (231.2 MG)Vetoquinol N A Inc · Status since Aug 201300763632Cancelled Post Market
GALLIMYCIN-200 (USP STERILE ERYTHROMYCIN INJECTION) (200 MG)Vetoquinol N A Inc · Status since Jul 201202172674Cancelled Post Market
GALLIMYCIN-36 (50 MG)Vetoquinol N A Inc · Status since Jul 201202172682Cancelled Post Market
ILOTYCIN CRYST OP ONT 0.5% 52 (.5 %)Eli Lilly Canada Inc · Status since Jul 200200015970Cancelled Post Market
NOVO-RYTHRO ENCAP 250MG (250 MG)Novopharm Limited · Status since Aug 200500878669Cancelled Post Market
NOVO-RYTHRO STEARATE TAB 250MG (250 MG)Novopharm Limited · Status since Aug 200500391581Cancelled Post Market
NU-ERYTHROMYCIN-S 250MG TABLETS (250 MG)Nu-Pharm Inc · Status since Sep 201202051850Cancelled Post Market
PCE (333 MG)Amdipharm Limited · Status since Jun 201700769991Cancelled Post Market
SANS-ACNE SOLUTION (2 %)Galderma Canada Inc. · Status since Aug 200501902628Cancelled Post Market
STATICIN LOT (1.5 %)Westwood-Squibb, Division Of Bristol-Myers Squibb Canada Inc. · Status since Aug 200401910086Cancelled Post Market
STIEVAMYCIN FORTE (4 %)Glaxosmithkline Inc · Status since Aug 201501945262Cancelled Post Market
STIEVAMYCIN MILD (4 %)Glaxosmithkline Inc · Status since Aug 201502015994Cancelled Post Market
STIEVAMYCIN REGULAR (4 %)Glaxosmithkline Inc · Status since Jan 201601905112Cancelled Post Market
T-STAT LOT (2 %)Westwood-Squibb, Division Of Bristol-Myers Squibb Canada Inc. · Status since Aug 200402047802Cancelled Post Market
T-STAT PAD-LOT (2 %)Westwood-Squibb, Division Of Bristol-Myers Squibb Canada Inc. · Status since Aug 200402047799Cancelled Post Market

Notices of Compliance

Approvals of drug submissions that list it, newest first.